CMS Innovation Center: Obligations and Model Testing Progress

Why It Matters

Reduced funding and mixed model outcomes highlight the need for tighter performance oversight as the Innovation Center shapes Medicare and Medicaid reforms. The findings inform policymakers about the Center’s efficiency and impact on federal health‑spending goals.

Key Takeaways

• Obligated $11.4 billion across 70 tested models.
• Annual obligations fell 40% from 2015 peak.
• Four models expanded nationwide, delivering net savings.
• New long‑term goals set in May 2025 for performance.
• GAO recommends stronger performance‑management alignment.

Pulse Analysis

The Center for Medicare & Medicaid Innovation, created under the ACA, has become a pivotal testing ground for new health‑care delivery and payment structures. Over a 13‑year span it allocated $11.4 billion to 70 distinct models, reflecting a strategic shift from a $1.3 billion annual high in 2015 to $789 million in 2024. This funding contraction mirrors a narrower portfolio of active models—24 as of early 2025—and underscores the Center’s evolving focus on scalable, evidence‑based solutions rather than broad experimentation.

Outcomes from the Innovation Center are mixed but noteworthy. Four models have graduated to nationwide implementation, each reporting net savings that offset their testing costs, suggesting that targeted reforms can deliver fiscal benefits. The Center’s recent adoption of long‑term strategic goals and accompanying near‑term performance metrics marks a move toward more rigorous accountability. By aligning model evaluation with clear targets, the agency aims to demonstrate tangible value to both Congress and the public, addressing longstanding critiques about transparency and impact.

GAO’s latest review adds a critical layer of oversight, urging the Innovation Center to tighten its performance‑management practices. As federal health‑spending pressures mount, the Center’s ability to prove cost‑effectiveness will influence future legislative support and funding allocations. Stakeholders—from insurers to providers—should watch how the Center refines its model selection, scaling decisions, and reporting standards, as these factors will shape the next wave of health‑care innovation and potentially set new benchmarks for value‑based care nationwide.